HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Decrease of thrombomodulin contributes to the procoagulant state of endothelium in hemolytic uremic syndrome.

Abstract
The typical form of hemolytic uremic syndrome (D+HUS) is a thrombotic microangiopathy that causes acute renal failure in children. The etiology of this disease is a toxin called Shiga-like toxin (Stx), present in certain strains of gram-negative bacteria. Vascular endothelial cell (EC) injury appears to be central in the pathogenesis of D+HUS. Thrombomodulin (TM) is a glycoprotein present in EC with anti-thrombogenic properties. The objective of this study was to investigate the effects of Stx on the surface expression of TM in EC using an in vitro culture of human glomerular microvascular endothelial cells. We also evaluated other inflammatory mediators [tumor necrosis factor-alpha (TNF-alpha) and lipopolysaccharide], which are known to increase Stx receptor expression and are potentially involved in the pathogenesis of D+HUS. Stx2 induced a significant decrease of TM expression in this cell type after pre-incubation with TNF-alpha. This decrease could not be attributed to the inhibition of protein synthesis only, as cycloheximide, another inhibitor of protein synthesis, did not affect TM surface expression. These results suggest that the Stx2-induced decrease of TM expression in glomerular EC might contribute to the local procoagulant state present in D+HUS.
AuthorsGabriela C Fernández, Maroeska W M Te Loo, Thea J A van der Velden, Lambert P W van der Heuvel, Marina S Palermo, Leo L A Monnens
JournalPediatric nephrology (Berlin, Germany) (Pediatr Nephrol) Vol. 18 Issue 10 Pg. 1066-8 (Oct 2003) ISSN: 0931-041X [Print] Germany
PMID12920633 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Inflammation Mediators
  • Shiga Toxin 2
  • Thrombomodulin
  • Tritium
  • Leucine
Topics
  • Cells, Cultured
  • Endothelial Cells (cytology, metabolism)
  • Endothelium, Vascular (cytology, metabolism)
  • Glomerular Mesangium (blood supply)
  • Hemolytic-Uremic Syndrome (etiology, metabolism)
  • Humans
  • Inflammation Mediators (metabolism)
  • Leucine (pharmacokinetics)
  • Microcirculation
  • Shiga Toxin 2 (pharmacology)
  • Thrombomodulin (metabolism)
  • Tritium

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: